These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29318382)

  • 1. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
    Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation.
    Mazzoccoli L; Robaina MC; Bacchi CE; Soares Lima SC; Klumb CE
    Oncol Rep; 2019 Aug; 42(2):775-784. PubMed ID: 31173259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
    Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
    Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAMLF is a target of miR-181b in Burkitt lymphoma.
    Li JG; Ding Y; Huang YM; Chen WL; Pan LL; Li Y; Chen XL; Chen Y; Wang SY; Wu XN
    Braz J Med Biol Res; 2017 May; 50(6):e5661. PubMed ID: 28492808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
    Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
    Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
    Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
    Wang M; Yang W; Li M; Li Y
    Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
    Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
    Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.
    Robaina MC; Faccion RS; Mazzoccoli L; Rezende LM; Queiroga E; Bacchi CE; Thomas-Tikhonenko A; Klumb CE
    Ann Hematol; 2016 May; 95(6):881-91. PubMed ID: 27044389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
    Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
    Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
    Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
    Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
    J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
    Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
    BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
    Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
    BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.